In addition, these findings need to be corroborated with multicentre casecontrol studies to bring out nationally relevant risk factors for mdr tb. According to the national sentinel drug resistance survey conducted in 20122014, 2. Antibiotics free fulltext predictors of multidrugresistant. Risk factors for multidrug resistant tuberculosis patients in amhara national regional state. Also, in 2016 about 19% of previously treated tb cases were estimated to have either rifampicin or multi drug resistant tb. The most powerful predictor of the emergence of mdr tb reported in ethiopia is previous exposure to anti tb drug treatment. The thesis provided some policy recommendations that could assist to achieve the endtb targets. Mdr rr tb cases started on secondline treatment in 2016 72% 703 xdr tb cases started on secondline treatment in 2016 tb preventive treatment, 2018. The main aim of the report is to provide a comprehensive and uptodate assessment of the tb epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. Current treatment of multidrug resistant tuberculosis in ethiopia. Surveillance of drug resistance tuberculosis based on.
Efforts to control the global burden of tuberculosis tb have been jeopardized by the rapid evolution of multidrug resistant mycobacterium tuberculosis mtb, which is resistant to at least isoniazid and rifampicin. Multidrug resistant tuberculosis mdr tb is becoming a major challenge of the tuberculosis tb control program in ethiopia. Ethiopia tuberculosis profile world health organization. This study determined risk factors associated with mdr tb among mdr tbhiv coinfected cases and tbhiv coinfected controls attending art clinics in addis ababa. Pdf severe adverse effects associated with multidrug. Spatial patterns of multidrug resistant tuberculosis and. To determine risk factors of mdrtb patients in amhara national regional state, ethiopia. Wondemagegn mulu1, daniel mekonnen1, mulat yimer1, aschalew admassu2, bayeh abera1 1.
Pdf tuberculosis burden in ethiopia from 1990 to 2016. In ethiopia the mdr tb prevalence based on the 2005 nationwide survey was 1. However, there are very few studies in africa that have assess the spatial distribution of tb. Cases of multidrugresistant tuberculosis mdrtb are rising, which is a. Clements1 1 research school of population health, college of medicine, biology and environment, the australian. However, little is known about pulmonary tuberculosis preventive practices among bus users in ethiopia.
Tb usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. Annually 20002500 mdr tb cases are estimated to occur among the notified pulmonary tb cases. However, to our knowledge, no study was done to assess risk factors for multi drug resistant tuberculosis targeting mdrtbhiv and tbhiv patients. Federal democratic republic of ethiopia ministry of health. We analyzed a previously published collection of m. The main source of infection is untreated smearpositive pulmonary. Ethiopia is one of the countries with high multidrugresistant tuberculosis mdr tb burden. Drugresistant tuberculosis, lebanon, 2016 2017 volume. This study identifies factors associated with the occurrence of mdr tb in patients who underwent firstline tb treatment in addis ababa city. Mdr and non mdr tb cases were compared on key sociodemographic and patient.
The yield of screening symptomatic contacts of multidrug. Risk factors of multidrug resistant tuberculosis in addis. The approach should be promoted for wider adoption and dissemination. Worldwide, there were 650,000 multidrugresistant tuberculosis mdr tb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdr tb. Aug 28, 20 worldwide, there were 650,000 multidrugresistant tuberculosis mdr tb cases in 2010, and in 2008 the world health organization estimated that 150,000 deaths occurred annually due to mdr tb. Smear positive tuberculosis patients are responsible for up to 90% of transmission occurring in the community. Rifampicin resistance was lower than 2% in new cases. Lineprobe assay and molecular typing reveal a potential. Multidrugresistant tuberculosis mdrtb has continued to be a challenge for tuberculosis tb control globally. Review open access multidrugresistant tuberculosis in. According to the who report, the prevalence of mdr. The result of this study highlight treatment success among mdrtb is below acceptable. Likewise, two studies reported xdr tb in the range of 1% 4. Ethiopia is also one of the 27 high mdr tb burden countries.
Mdr rrtb cases started on secondline treatment in 2016 72% 703 xdrtb cases started on secondline treatment in 2016 tb preventive treatment, 2018. Pdf cdc pdf 37k multidrugresistant tuberculosis mdr tb what is tuberculosis tb. Current treatment of multidrug resistant tuberculosis in. Department of medical microbiology, immunology and parasitology, college of medicine and health sciences, bahir dar university, ethiopia 2. The diagnosis of mdr tb can take several months or even longer often too late for the patient. Improving tuberculosis control in ethiopia 1 daniel gemechu datiko 1. Experts involved in the development of the who treatment guidelines for drugresistant tb.
Ethiopia tuberculosis profile population 2018 109 million estimates of tb burden. Comparative crosssectional study was conducted to determine the risk factors for mdr tb in addis ababa. Ethiopia is one of the 30 mdrtb highburden countries, with an estimated 5800 cases reported in 2016 with the prevalence rate of 2. Free fulltext pdf articles from hundreds of disciplines, all in one place multidrugresistant tuberculosis in ethiopia. Drugresistant tb continues to be a public health crisis. Previous studies have documented variable prevalences of multidrugresistant tuberculosis mdr tb and its risk factors in ethiopia. Costs faced by multidrug resistant tuberculosis patients during. This study aimed to assess the level of pulmonary tuberculosis ptb preventive practices and. Lineprobe assay and molecular typing reveal a potential drug. Tuberculosis tb is a chronic infectious disease caused by mycobacterium tuberculosis. Secondline drug susceptibility testing dst and individualized xdr. Antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide. The objective of the study was to investigate risk factors for mdr tb in addis ababa. This study aimed to assess the level of pulmonary tuberculosis ptb preventive practices.
Studies that reported a prevalence of mdrtb among new and previously. Ethiopia has a high prevalence of tuberculosis tb and is one of the 22 highest tb. Ethiopia is among the countries highly affected with mdr tb. Pulmonary tuberculosis preventive practices among anibessa. Likewise, two studies reported xdrtb in the range of 1% 4. Links with this icon indicate that you are leaving the cdc website the centers for disease control and prevention cdc cannot attest to the accuracy of a nonfederal website. Study subjects were selected using multistage probability sampling. The programmatic management of multidrugresistant tuberculosis mdr tb is entirely based on a who recommended longterm, 1824 month lasting treatment regimen.
Mdr tb develops when a patient receives ineffective treatment or treatment is interrupted, a common occurrence when people are subjected to violence and insecurity. Untreated, mdr tb is a deadly disease affecting impoverished people who cannot afford timely diagnosis and adequate treatment for this curable illness. In this study, we used the 2016 global burden of diseases, injuries and risk. Risk factors for multidrug resistant tuberculosis patients. Management of these adverse reactions symptomatically withwithout modification of the mdr tb regimen was noted if documented in the case file treatment card. Ethiopia is one of the high multidrugresistant tuberculosis mdr tb burden countries. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regimen.
The thesis identified the areas where tb and mdr tb are clustered in northwest ethiopia. The identified risk factors should be given priority by tb control programs under addis ababa health bureau to control mdr tb. This finding presents a serious challenge for tb control in somalia. Tuberculosis treatment outcomes in ethiopia from 2003 to. Although the burden of mdr tb in ethiopia is increasing, there is. In this study, we used the 2016 global burden of diseases, injuries and risk factors gbd data to analyze the incidence, prevalence and mortality rates of tuberculosis tb in ethiopia over the. To investigate the opportunities and challenges faced by treatment followup health centres tfcs when managing mdr tb patients, with greater focus on recording, tb infection control ic and. Up to date, the mdr tb treatment outcome is not sufficiently understood in ethiopia. M workshop facing the reality of mdr tb new delhi, india. Our resources improve and expand tb diagnostic and treatment services and screening in rural areas and among.
Prevalence of multidrugresistant tuberculosis and associated. Guidelines fourth, diagnosing mdr tb cases among previously treated patients and providing effective treatment will greatly help in halting the spread of mdr tb. This edition also addresses the prevention of acquired mdr tb, especially among new tb patients. Ethiopia is 15th among the 27 mdr tb highburden countries. Linking to a nonfederal website does not constitute an endorsement by cdc or any of its employees of the sponsors or the information and products presented on the website. Risk factors for multidrug resistant tuberculosis patients in amhara.
Global tuberculosis report 2019 who has published a global tb report every year since 1997. Jan 22, 2017 kncv tuberculosis foundation is looking for a fulltime. Efforts by the national tb programme to control mdr tb include expanding ambulatory care. Pdf current treatment of multidrug resistant tuberculosis in. Multidrugresistant tuberculosis, somalia, 20102011. Jun 04, 2017 new ethiopian tb guildline november 2016 1.
Even most recent reported mdr tb rates largely relied on estimates rather than on systematic laboratory confirmation. Open access research drugsusceptible tuberculosis treatment. Kncv tuberculosis foundation is looking for a fulltime. Determinants of multidrugresistant tuberculosis in patients.
The most powerful predictor of the emergence of mdr tb reported in ethiopia is previous exposure to antitb drug treatment. Therefore, this study determined risk factors for mdr tb among. Mdrtb clinicianinternist addis ababa, ethiopia kncv. Tuberculosis tb is a disease caused by bacteria that are spread from person to person through the air. Treatment outcomes for multidrugresistant tuberculosis. Up to date, the mdrtb treatment outcome is not sufficiently understood in ethiopia. Who treatment guidelines for drug resistant tuberculosis. The last national survey on the prevalence of drugresistant tb in lebanon was performed 15 years ago, well before the beginning of the syria crisis in 2011. In 2017 an estimate indicated that the incidence of mdr tb in ethiopia is 2. Therefore, this analysis aimed to determine the pooled. Risk factors for multidrug resistant tuberculosis in. Mdr tb planning toolkit introduction and users guide 3 mdr tb planning toolkit introduction and users guide. Adverse drug reactions in management of multi drug. The burden of mdrtb remains high in ethiopian settings, especially in.
Pdf the emergence of drugresistant tuberculosis tb, particularly multidrugresistant mdr and extensively drugresistant xdr tb, is a major. This quantitative, descriptive study investigated risk factors for mdr tb in addis ababa, ethiopia. Pdf the emergence of drugresistant tuberculosis tb, particularly multidrug resistant mdr and extensively drugresistant xdr tb, is a major. Adverse drug reactions in management of multi drug resistant. This study identifies factors associated with the occurrence of mdr tb in patients who underwent firstline tb treatment in addis. The emergence of drugresistant tuberculosis tb, particularly multidrugresistant mdr and extensively drugresistant xdr tb, is a major public health problem. The burden of tuberculosis tb has not been comprehensively evaluated over the last 25 years in ethiopia. New ethiopian tb guildline november 2016 slideshare. Risk factors for multidrugressistant tuberculosis in addis ababa, ethiopia by fikadu tadesse nigusso submitted in accordance with the requirements for the degree of. Ethiopia is among the 30 high tb, hiv and mdr tb burden countries, with annual estimated tb incidence of 177100,000 populations and death rate of 25 per 100,000 populations for 2016.
Prevalence of tuberculosis, multidrug resistant tuberculosis and. This set of tools is designed to help countries develop or strengthen a multidrugresistant tuberculosis mdr tb component within their national tb strategy. In addition, studies in zimbabwe, south africa, and ethiopia associate high. Dec 21, 2014 the national tb programme ntp is responsible for the programmatic management of mdr tb in ethiopia. Risk factors for multidrug resistant tuberculosis patients in. A total of 439 medical records belonging to mdr tb and non mdr tb patients managed in public health centres from january 2008 to december 2011 were analysed. There is a paucity of evidence that assessed studies on the treatment of mdr tb, which focus on the effectiveness of the directly. Efforts to expand diagnostic services, treatment and care. Spatial patterns of multidrug resistant tuberculosis and relationships to socioeconomic, demographic and household factors in northwest ethiopia kefyalew addis alene1,2, kerri viney1, emma s. A study of mdrtb patient costs in march 20 indicated that the average total. Mdr tb, rifapentine for pregnant women and children with latent tb infection ltbi. Treatment success rates of multidrugresistant tuberculosis mdr tb is a key issue that cannot be ignored. Phd thesis improving tuberculosis control in ethiopia.
The treatment outcomes of mdr tb were assessed in ethiopia and china, and a clinical risk score was developed for the prediction of poor treatment outcomes. Determinants of multidrugresistant tuberculosis in. Epidemiology of multidrugresistant tuberculosis mdrtb. According to the 2014 who global tb report, 22 high burden countries account for 80 percent of the global tb cases and ethiopia has the tenth highest tb burden in the world. Multidrug resistant tuberculosis in ethiopian settings and. These levels of drug resistance are among the highest ever documented in africa and the middle east. Ethiopia is one of those countries where such information is lacking despite the fact that tb treatment nonadherence level is high ranging from 10% to 21% 2628, and the prevalence of mdr tb is also increasing from 1. Provided by the centers for disease control and prevention cdc. A drug resistance survey conducted in 2011 in somalia showed that the country had the highest rate of mdr tb infection on the african continent. Kncv is the lead partner in challenge tb, the usaidfunded 5year global program to decrease tb mortality and morbidity in high burdened countries. Multidrug resistant tuberculosis in ethiopian settings and its. Oct 03, 2014 likewise, two studies reported xdrtb in the range of 1% 4. Tracing symptomatic contacts of mdr tb cases could be a high yield strategy for early detection and treatment of mdr tb cases in the community.
1093 849 692 1300 958 174 915 146 132 873 1247 254 609 242 1163 216 833 1405 1361 763 182 1549 1164 160 959 974 3 641 694 747 1421 94 489 544